Navigation Links
QED International Announces Changes to the HealthShares(TM) Orthopedic Repair Index
Date:11/19/2007

NEW YORK, Nov. 19 /PRNewswire/ -- QED International, administrator for the HealthShares(TM) Exchange-Traded Funds, a series of 20 underlying fund portfolios, today announced that effective at the opening of trading on Wednesday November 21, 2007, Anika Therapeutics Inc. (Nasdaq: ANIK) will replace DJO Incorporated (NYSE: DJO) in the HealthShares(TM) Orthopedic Repair Index. Companies included in the HealthShares(TM) Orthopedic Repair Index are engaged manufacturing, distribution, and/or commercialization of medical devices, pharmaceuticals and/or regenerative medicine for the treatment of bone, cartilage, tendon, muscle, ligament, maxillofacial and dental elements, excluding periodontal and skin conditions or disorders.

About HealthShares(TM)

XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are organized into therapeutic 'verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcar
'/>"/>

SOURCE QED International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 A common approach to treating kidney ... not improve survival chances for people who suddenly developed ... the University of Pittsburgh School of Medicine. , Their ... , suggest acute hemodialysis, an aggressive method that is ... not provide a definitive benefit to the patient. , ...
(Date:8/20/2014)... (August 20, 2014) Research from Columbia University Medical ... in stomach cancer growth and that blocking nerve signals ... treatment for the disease. The study was conducted by ... with Duan Chen, MD, PhD, in Norway and is ... . , "Scientists have long observed that human and ...
(Date:8/20/2014)... 20, 2014 The non-small cell lung ... in the offing across the top 8 developed nations, ... to around USD 8 billion by 2020-end, posting a ... is projected to be driven by innovative therapies entering ... lacking efficient treatment, unlike the non-squamous segment. Thus, patients ...
(Date:8/20/2014)... Rosa, CA (PRWEB) August 20, 2014 The ... the 12 per diode panel band perfect spectrum that encompasses ... are most likely to use during photosynthesis. A key ... bands is that they almost exclusively reside between 440-480 on ... on the red side of the spectrum. The KIND LED ...
(Date:8/20/2014)... MI (PRWEB) August 20, 2014 In its ... drug and alcohol treatment program that gets clients off to ... recovery they can believe in, is highlighting an important and ... be heeded by everyone who wants to understand the insidious ... are of the belief that drug abuse targets a certain ...
Breaking Medicine News(10 mins):Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4Health News:Cheap LED Grow Lights Are Quickly Being Replaced by Premium Grow Lights 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3
... Oct. 20 Strong new pledges of,commitment ... donors, government,officials, corporations, foundations and non-governmental organizations,today ... Deliver conference, which,sought to mobilize political will ... worldwide. More than 1,800 participants from ...
... YORK, Oct. 20 EmPower Research, LLC, a ... Consulting, launched its,first-ever study on the Indian Contract ... titled ,Indian Contract Research Industry, (CRO-nicles),captures the industry,s ... to the top line industry executives first hand. ...
... Following is a statement,by Linda A. Suydam, D.P.A., ... the recommendations issued today by the U.S.,Food and ... Committee. At a meeting this week, the joint ... medicines in children., "For decades, parents and ...
... Court, WILMINGTON, Del., Oct. 19 The following,statement ... W.Va., zinc,smelter class action lawsuit. The statement is to ... "We are extremely disappointed by the outcome of the ... unfairly punished for doing,the right thing for this property ...
... Mass., Oct. 19 LeMaitre Vascular,Inc. (Nasdaq: ... and implants for the treatment of peripheral vascular ... Annual Healthcare Conference on,Tuesday, November 6, 2007, in ... George W. LeMaitre, Chairman and Chief Executive Officer, ...
... the less the idea bothered her , , FRIDAY, Oct. ... the idea of childlessness than men, new research shows, ... how each gender views the pressures of parenthood. , ... and parenthood mean different things," said study author Tanya ...
Cached Medicine News:Health News:Women Deliver Conference Launches New Commitments 2Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:DuPont Responds to Spelter, W.Va., Lawsuit Decision 2Health News:Childlessness Bothers Men More Than Women 2Health News:Childlessness Bothers Men More Than Women 3
(Date:8/20/2014)... Trovagene, Inc. (NASDAQ:   TROV), a developer ... two clinical studies will be presented at the 29th ... test for the detection of high risk strains of ... take place in Seattle from ... a new U.S. patent was issued earlier this year ...
(Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
(Date:8/19/2014)... , Aug. 19, 2014 Minimally Invasive Devices ... medical device company, announced today that Mitsubishi Corporation has ... robotic visualization system in Japan . ... in Japan in the second ... the exclusive distributor for Karl Storz GMBH & Co. ...
Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: